北京某三级综合医疗机构实施处方前置审核效果  

Effect and Practice of Pre-prescription Review in a Third-Level Medical Institution in Beijing

作　　者：陈慧[1] 王诗卉[1] 张东肃 赵瑞[1] 于晓佳[1] 苏晔[1] 刘丽宏[1] CHEN Hui;WANG Shihui;ZHANG Dongsu;ZHAO Rui;YU Xiaojia;SU Ye;LIU Lihong(Department of Pharmacy,Beijing Chaoyang Hospital,Capital Medical University,Beijing 100010,China)

机构地区：[1]首都医科大学附属北京朝阳医院药事部,北京100010

出　　处：《医药导报》2020年第9期1203-1205,共3页Herald of Medicine

摘　　要：目的评估药师实施处方前置审核的药学服务价值。方法抽取北京某三级综合医疗机构处方前置审核流程改造前1年和改造后3年的1周处方,以相同的标准进行处方评价,比较前后的处方问题差异,评估开展此项药学服务产生的效果。结果相对于流程改造前,人均用药数量从3.97种降至3.04种;人均药费从380.02元降至337.65元。不合格医嘱的比例从12.21%降至0.36%。其中无适应证用药从6.18%降至0.03%;用法用量不适宜从4.61%降至0.32%;联合用药不适宜从1.24%降至0.01%;禁忌证用药从0.18%降至0.00%。结论药师通过提供处方前置审核服务,可降低明显用药风险,降低患者的药费支出。Objective To evaluate the value of pharmaceutical care through the pre-prescription review provided by pharmacists.Methods One-week’s prescriptions from one year before and three years after the reform of the pre-audit process in a Third-Level medical institution in Beijing were selected,and the prescription was evaluated with the same auditing standard.The difference of prescription problems before and after the reform of pre-audit process,were compared to evaluate the value of pharmaceutical care.Results Compared with the pre-reform period,the number of drugs per capita decreased from 3.97 to 3.04;per capita drug cost decreased from 380.02 yuan to 337.65 yuan.The percentage of unqualified orders fell from 12.21%to 0.36%.among which drug use for no indication decreased from 6.18%to 0.03%;unsuitable usage and dosage decreased from 4.61%to 0.32%;unsuitable combination of drugs decreased from 1.24%to 0.01%;and contraindications decreased from 0.18%to 0.00%.Conclusion Pharmacists can reduce the risk of drug use and the average drug cost for each patient by providing pre-prescription audit services.

关 键 词：处方前置审核 合理用药 药学服务 

分 类 号：R951[医药卫生—药学] R969.3